A comparative study of two immunoassays of maternal placental growth factor

References

• Muller YA, Christinger HW, Keyt BA, et al. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding. Structure. 1997;5(10):1325–1338.
   PubMed Web of Science ®Google Scholar
• Iyer S, Leonidas DD, Swaminathan GJ, et al. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem. 2001;276(15):12153–12161.
   PubMed Web of Science ®Google Scholar
• Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell. 2002;1(1):99–108.
   PubMed Web of Science ®Google Scholar
• McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell. 1993;73(3):421–424.
   PubMed Web of Science ®Google Scholar
• Maglione D, Guerriero V, Viglietto G, et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 1991;88(20):9267–9271.
   PubMed Web of Science ®Google Scholar
• Holmes DIR, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6(2):209.
   PubMed Web of Science ®Google Scholar
• Park JE, Chen HH, Winer J, et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem. 1994;269(41):25646–25654.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia a prospective multicenter study. Circulation. 2013;128(19):2121–2131.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187(1):127–136.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22.
   PubMed Web of Science ®Google Scholar
• Torry DS, Wang HS, Wang TH, et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179(6):1539–1544.
   PubMed Web of Science ®Google Scholar
• Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160(4):1405–1423.
   PubMed Web of Science ®Google Scholar
• Turpin CA, Sakyi SA, Owiredu WK, et al. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Preg Childbirth. 2015;15:189–192.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA. 2005;293(1):77–85.
   PubMed Web of Science ®Google Scholar
• Tidwell SC, Ho HN, Chiu WH, et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynaecol. 2001;184(6):1267–1272.
   PubMed Web of Science ®Google Scholar
• Madazli R, Kuseyrioglu B, Uzun H, et al. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynecol Obstet. 2005;89(3):251–257.
   PubMed Web of Science ®Google Scholar
• Vaisbuch E, Whitty JE, Hassan SS, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynaecol. 2011;204:152–159.
   PubMed Web of Science ®Google Scholar
• Duhig KE, Myers J, Seed PT, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019;6736:33212–33214.
   Google Scholar
• Sharp A, Chappell LC, Dekker G, et al. Placental growth factor informed management of suspected pre-eclampsia or fetal growth restriction: the MAPPLE cohort study. Preg Hypert. 2018;14:228–233.
   PubMed Web of Science ®Google Scholar
• Hayes-Ryan D, Hemming K, Breathnach F, et al. PARROT Ireland: placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol. BMJ Open. 2019;9(2):e023562.
   PubMed Web of Science ®Google Scholar
• NICE Diagnostics guidance [DG23] [Internet]. PlGF-based testing to help diagnose suspected pre-eclampsia. London (UK): NICE; 2016. Available from: https://www.nice.org.uk/guidance/dg23/chapter/1-Recommendations
   Google Scholar
• R&D Systems [Internet]. Human PlGF Quantikine ELISA Kit Summary. Minneapolis (MN): R&D Systems; 2016. Available from: https://www.rndsystems.com/products/human-plgf-quantikine-elisa-kit_dpg00
   Google Scholar
• Quidel [Internet]. Triage PlGF Test. San Diego (CA): Quidel; 2013. Available from: https://www.quidel.com/immunoassays/triage-test-kits/triage-plgf-test
   Google Scholar
• Cheng YKY, Poon LCY, Shennan A, et al. Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor. Pregnancy Hypertens. 2019;17:165–171.
   PubMed Web of Science ®Google Scholar
• Cao YH, Ji WDR, Qi P, et al. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun. 1997;235(3):493–498.
   PubMed Web of Science ®Google Scholar
• Yang W, Ahn H, Hinrichs M, et al. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. J Repro Immunol. 2003;60(1):53–60.
   PubMed Web of Science ®Google Scholar
• Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors. 1993;9(4):259–268.
   PubMed Web of Science ®Google Scholar
• McCarthy FP, Gill C, Seed PT, et al. Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study. Ultrasound Obstet Gynecol. 2019;53(1):62–67.
   PubMed Web of Science ®Google Scholar
• Frampton GK, Jones J, Rose M, et al. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technol Assess. 2016;20(87):1–160.
   Web of Science ®Google Scholar
• British Braodcasting Company (BBC) [Internet]. NHS to offer mums-to-be new blood test for pre-eclampsia. London (UK): BBC; 2019. Available from: https://www.bbc.com/news/health-47771688
   Google Scholar
• Maynard SE, Moore Simas TA, Solitro MJ, et al. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. Am J Obstet Gynecol. 2008;198(2):200.e1–200.e7.
   PubMed Web of Science ®Google Scholar
• Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010;5(10):e13263.
   PubMed Web of Science ®Google Scholar
• Sanchez O, Llurba E, Marsal G, et al. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology. Human Repro. 2012;27(2):358–365.
   PubMed Web of Science ®Google Scholar
• Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012;60(2):451–458.
   PubMed Web of Science ®Google Scholar
• Droge L, Herraiz I, Zeisler H, et al. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Ultrasound Obstet Gynecol. 2015;45(3):286–293.
   PubMed Web of Science ®Google Scholar
• Internataional Society for Biological and Enviromental Repositories (ISBER) [Internet]. Best practices for repositories. Bethesda (MD): ISBER; 1999. Available from: https://www.isber.org/page/BPR
   Google Scholar
• Americal Society for Quality (ASQ) [Internet]. ISO 9001:2015 – Quality Management Systems. Milwaukee (WI): ASQ; 2015. Available from: https://asq.org/quality-resources/iso-9001
   Google Scholar
• Organisation for Economic Co-operation and Development (OECD) [Internet]. Guidelines for mutinational enterprises. Paris (France): OECD; 2011. Available from: http://www.oecd.org/investment/mne/1922428.pdf
   Google Scholar
• Law LW, Sahota DS, Chan LW, et al. Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women. J Mat-Fet & Neonat Med. 2010;23:1475–1480.
   PubMed Web of Science ®Google Scholar
• Westfall JM, Mold J, Fagnan L. Practice-based research-“Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–406.
   PubMed Web of Science ®Google Scholar
• Woolf SH. The meaning of translational research and why it matters. JAMA. 2008;299(2):211–213.
   PubMed Web of Science ®Google Scholar
• Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation? N Engl J Med. 2003;349(9):868–874.
   PubMed Web of Science ®Google Scholar